Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 693-704

  Yang, Yongmin ^a   Hao, Junshan ^a   Liu, Xiangdang ^a   Dalkin, Bruce ^a   Nagle, Ray B ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; RNA;

ARTICLE; AUTOPSY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RNA TRANSLATION;

CARCINOMA; HUMANS; IN SITU HYBRIDIZATION; KERATINS; MALE; NEOPLASM INVASIVENESS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES; RNA, MESSENGER;

EID: 0031033250     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bostwick DG: Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem 1992, 16H:10-19
2. Brawer MK: Prostatic intraepithelial neoplasia: a premalignant lesion. Hum Pathol 1992, 23(3):242-248
3. Nagle RB: Cytokeratin expression in carcinoma. Biochem Mol Aspects Selected Cancer 1994, 2:387-410
4. Brawer MK, Peehl DM, Stamey TA, Bostwick DG: Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985, 45:3663-3667
5. Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Cleniker A: Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 1987, 47:281-286
6. Nagle RB, Brawer ML, Kittelson J, Clark V: Phenotypic relationships of prostatic dysplasia to prostatic carcinoma. Am J Pathol 1991, 138:119-128
7. Okada H, Tsubura A, Okamura A, Senzaki H, Naka Y, Komatz Y, Morii S: Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat 1992, 421:157-161
8. Purnell DM, Heatfield BM, Anthony RL, Trump BF: Immunohistochemistry of the cytoskeleton of human prostatic epithelium: evidence for disturbed organization in neoplasia. Am J Pathol 1987, 126:384-395
9. Verhagen APM, Frans CS, Ramaekers TW, Aalders H, Schaafsma E, Debruyne FMJ, Schalken JA: Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992, 52:6182-6187
10. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York, John Wiley and Sons, 1994
11. Stasiak PC, Lane EB: Sequence of cDNA coding for human keratin 19. Nucleic Acids Res 1987, 15:10-58
12. Marchuk D, McCrohon S, Fuchs E: Complete sequence of a gene encoding a human type I keratin: sequences homologous to enhance elements in the regulatory region of the gene. Proc Natl Acad Sci USA 1985, 82:1609-1613
13. Kulesh DA, Cecena G, Darmon YM, Vasseyr M, Oshima RG: Posttranslational regulation of keratins: degradation of mouse and human keratin 18 and 8. Mol Cell Biol 1989, 9:1553-1565
14. Lersch R, Fuchs E: Sequence and expression of a type II keratin, K5, in human epidermal cells. Mol Cell Biol 1988, 8:486-493
15. Ray Chauhury A, Marchuk D, Lindhurst M, Fuchs E: Three tightly linked genes encoding human type I keratins: conservation of sequence in the 5′-upstream regions of the coexpressed keratin genes. Mol Cell Biol 1986, 6:539-548
16. McNeal JE, Bostwick DG: Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986, 17:64-71
17. Evans GS, Chandler J: Cell proliferation studies in rat prostate. I. The proliferative role of basal and secretory epithelial cells during normal growth. Prostate 1987, 10:163-178
18. English HF, Santen RI, Isaacs JT: response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987, 11:229-242
19. Bazer GT: Basal cell proliferation and differentiation in regeneration of the rat ventral prostate. Invest Urol 1980, 17:470-473
20. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994, 24:114-118
21. Dermer GB: Basal cell proliferation in benign prostatic hyperplasia. Cancer 1978, 41:1857-1862
22. Devaraj LT, Bostwick DG: Atypical basal cell hyperplasia of the prostate. Am J Surg Pathol 1993, 17:645-659
23. Glynne-Jones E, Harper ME: Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures. Prostate 1992, 20:133-150
24. Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnorml prostatic growth: a stem cell model. Prostate 1996, 28:98-106
25. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA: Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol 1991, 22:644-652
26. Leask A, Byrne C, Fuchs E: Transcription factor AP2 and its role in epidermal-specific gene expression. Proc Natl Acad Sci USA 1991, 88:7948-7952
27. Leask A, Rosenberg M, Vassar R, Fuchs E: Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes Dev 1990, 4:1985-1988
28. Byrne C, Tainsky M, Fuchs E: Programming gene expression in developing epidermis. Development 1994, 120:2369-2383
29. Byrne C, Fuchs E: Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol Cell Biol 1993, 13:3176-3190
30. Faus I, Hsu HJ, Fuchs E: Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol Cell Biol 1994, 14:3263-3275
31. Crissman JD, Sakr WA, Hussein ME, Pontes JE: DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate. Prostate 1993, 22:155-162
32. Drachenberg CB, Papadimitriou JC: Aberrant pattern of lectin binding in low and high grade prostatic intraepithelial neoplasia. Cancer 1995, 75:2539-2544
33. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM: Allelic loss on chromosome 8p 12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995, 55:2959-2962
34. Ibrahim GK, Kerns BJ, MacDonald JA, Ibrahim SN, Kinney RB, Humphrey PA, Robertson CN: Differential immune-reactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J Urol 1993, 149:170-173
35. Montironi R, Galluzzi CM, Diamanti L, Giannulis I, Pisani E, Scarpelli M: Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei. Virchows Arch A Pathol Anat Histopathol 1993, 422:185-192
36. Petein M, Michael P, Van Velthoven R, Pasteels JL, Brawer MK, Davis JR, Nagel RB, Kiss R: Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol 1991, 96:628-634
37. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP: High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994, 8:439-443
38. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE, Macoska JA: Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate 1994, 25:199-205
39. Weinberg DS, Weidner N: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma: evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma. Arch Pathol Lab Med 1993, 117:1132-1137
40. Sun TT, Eichner R, Schermer A, Cooper D, Nelson WG, Weiss RA: Classification, expression, and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. The transformed Phenotype: Cancer Cells, vol 1. Edited by AJ Levine, GF Van der Woude, WC Topp, JD Watson, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, pp 169-176.
41. Paladini RD, Takahashi K, Gant TM, Coulombe PA: cDNA cloning and bacterial expression of the human type I keratin 16. Biochem Biophys Res Commun 1995, 215:517-523
42. Smedts F, Ramaekers F, Leube RE, Keijser K, Link M, Vooijs GP: Expression of keratin 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma, Am J Pathol 1993, 142:403-412
43. Weiss RA, Eichner Rand Sun TT: Monoclonal antibody analysis of keratin expression in epithelial diseases: a 48kd keratin as molecular markers for keratinocyte hyperproliferation. J Cell Biol 1984, 98:1397-1406
44. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudad LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines Cancer Res 1991, 51:3972-3981
45. Hu L, Gudas LJ: Activation of keratin gene expression by a 3′ enhancer containing an AP1 site. J Biol Chem 1994, 269:183-191
46. Moles JP, Schiller JT, Tesniere A, Leigh IM, Guilhou JJ, Basset-Seguin N: Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sci 1994, 107:435-441
47. Moyret-Lalle C, Marcais C, Jacquemier J, Moles JP, Daver A, Soret JY, Jeanteur P, Ozturk M, Theillet C: ras, p53, and HPV status in benign and malignant prostate tumors. Int J Cancer 1995, 64:124-129
48. Wojno KJ, Epstein JI: The utility of basal cell-specific anti-cytokeratin antibody (34βE12) in the diagnosis of prostate cancer: a review of 228 cases. Am J Surg Pathol 1995, 19:251-260